- CLINICAL BRIEFINGS
Personalized mRNA vaccine induces strong, durable immunity in hard-to-treat breast cancer
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-026-00477-0
Figure 1 is published under a CC BY 4.0 licence.
References
Li, X. et al. Breast Cancer Res. Treat. 161, 279–287 (2017).
Sahin, U. et al. Nature 547, 222–226 (2017).
Vormehr, M. et al. Annu. Rev. Med. 70, 395–407 (2019).
Rojas, L. A. et al. Nature 618, 144–150 (2023).
Kranz, L. M. et al. Nature 534, 396–401 (2016).
Read the paper: Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC
A personalized cancer vaccine to prevent the return of high-risk kidney cancer
Bespoke vaccines can elicit long-lived immune activity against pancreatic cancer